Basel Medical Group Ltd (BMGL)

Market Cap	1.08M -95.9%
Revenue (ttm)	16.62M +89.5%
Net Income	-578,008
EPS	-0.60
Shares Out	1.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,815,773
Open	1.0600
Previous Close	1.9300
Day's Range	0.6000 - 1.0600
52-Week Range	0.6000 - 18.4800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About BMGL

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman’s health, and general practice services. In addition, the company’s services include consultation, medical diagnosis, and medical and surgical treatmen...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Feb 25, 2025
• Employees: 82
• Stock Exchange: Nasdaq
• Ticker Symbol: BMGL
• Website: https://baselmedical.com

Financial Performance

In fiscal year 2026, Basel Medical Group's revenue was 21.51 million, an increase of 89.46% compared to the previous year's 11.35 million. Losses were -747,995, -92.97% less than in 2025.

Financial numbers in SGD

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 12, 2026

Data Sources Report a data error